Stock Events

Stock Events

BNB Plus 

$0.158221
133
+$0.01+5.48% Friday 19:49

Statistics

Day High
0.16
Day Low
0.15
52W High
7.15
52W Low
0.07
Volume
204
Avg. Volume
181,545
Mkt Cap
1.14M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16DecExpected
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-37.5
-32.5
-27.5
-22.5
Expected EPS
N/A
Actual EPS
N/A

Financials

-3,251.66%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
2.14MRevenue
-69.49MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BNBX. It's not an investment recommendation.
Realty Income
3
O
Microsoft
2
MSFT
Tesla
2
TSLA
Vanguard S&P 500 UCITS - Dist
2
VUSA.LSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap32.95B
Illumina provides sequencing and array-based solutions for genetic analysis, competing in the biotechnology and diagnostics sectors similar to APDN.
QIAGEN N.V.
QGEN
Mkt Cap8.98B
Qiagen offers sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, directly competing with APDN's DNA-based technologies.
Pacific Biosciences of California
PACB
Mkt Cap419.62M
Pacific Biosciences offers sequencing systems that compete with APDN in the genomics and DNA sequencing markets.
Bio-Rad Laboratories
BIO
Mkt Cap10.32B
Bio-Rad Laboratories provides a range of products and systems used to separate complex chemical and biological materials, competing in the life sciences research and clinical diagnostics markets.
Thermo Fisher Scientific
TMO
Mkt Cap226.94B
Thermo Fisher Scientific offers a broad range of services and products, including analytical instruments and reagents, which compete with APDN's offerings in the life sciences sector.
Guardant Health
GH
Mkt Cap21.66B
Guardant Health focuses on liquid biopsies and cancer diagnostics, competing with APDN in the molecular diagnostics market.
Fulgent Genetics
FLGT
Mkt Cap542.88M
Fulgent Genetics provides comprehensive genetic testing solutions, competing with APDN in the DNA sequencing and genetic analysis market.
Adaptive Biotechnologies
ADPT
Mkt Cap3.87B
Adaptive Biotechnologies offers immune-driven medicine solutions, competing with APDN in the biotech sector focusing on genetic and molecular diagnostics.
CRISPR Therapeutics
CRSP
Mkt Cap5.39B
CRISPR Therapeutics is involved in gene editing, a field that overlaps with the genetic technologies and services provided by APDN.

About

BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a biotechnology firm dedicated to pioneering and commercializing technologies for the synthesis and identification of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company's operations are divided into three distinct business segments. Its Therapeutic DNA Production Services division specializes in the enzymatic manufacturing of synthetic DNA, used in the creation of nucleic acid-based treatments, and also develops and markets its proprietary RNA Polymerase (RNAP) for mRNA therapeutic production. The MDx Testing Services segment concentrates on developing clinical molecular diagnostic and genetic assessments, in addition to providing comprehensive clinical laboratory testing services. Lastly, the DNA Tagging and Security Products and Services segment leverages DNA detection techniques for securing industrial supply chains and offering various security solutions.
Show more...
CEO
Clay D. Shorrock
Employees
26
Country
United States
ISIN
US03815U6073
WKN
000A418YA

Listings

MU
DE
UDJ1.MU
OTC Link
US
BNBX
STU
DE
UDJ1.STU
BOATS
BOATS
BNBX.BOATS

0 Comments

Share your thoughts

FAQ

What is BNB Plus stock price today?▼
The current price of BNBX is $0.16 USD — it has increased by +5.48% in the past 24 hours. Watch BNB Plus stock price performance more closely on the chart.
What is BNB Plus stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange BNB Plus stocks are traded under the ticker BNBX.
What is BNB Plus market cap?▼
Today BNB Plus has the market capitalization of 1.14M
When is the next BNB Plus earnings date?▼
BNB Plus is going to release the next earnings report on December 16, 2026.
What is BNB Plus revenue for the last year?▼
BNB Plus revenue for the last year amounts to 2.14M USD.
What is BNB Plus net income for the last year?▼
BNBX net income for the last year is -69.49M USD.
How many employees does BNB Plus have?▼
As of September 14, 2026, the company has 26 employees.
In which sector is BNB Plus located?▼
BNB Plus operates in the Health & Wellness sector.
When did BNB Plus complete a stock split?▼
The last stock split for BNB Plus was on June 02, 2025 with a ratio of 1:15.
Where is BNB Plus headquartered?▼
BNB Plus is headquartered in Stony Brook, United States.